Barasertib(AZD1152-HQPA)
特别提示:包括Barasertib(AZD1152-HQPA)在内,本公司的所有产品仅可用于科研实验,严禁用于临床医疗及其他非科研用途!
CAS号 | 722544-51-6 |
分子式 | C26H30FN7O3 |
分子量 | 507.56 |
沸点 | 796.7°C at 760 mmHg |
折光率 | 1.68 |
溶解性 | DMSO ≥100mg/mL Water ≥100mg/mL Ethanol ≥2.8mg/mL |
存贮条件 | 储存温度-20℃ |
应用 | A highly selective ARK-2 inhibitor |
产品介绍 | AZD1152-HQPA是AZD-1152的活性代谢物,AZD1152-HQPA(Barasertib)是Aurora B高选择性抑制剂,IC50为0.37 nM,比对Aurora A的抑制性高100倍。 |
备注 | AZD1152-HQPA(Barasertib) is a highly selectiveAurora Binhibitor withIC50of 0.37 nM,~100 fold more selective for Aurora B over Aurora A. |
生化机理 | AZD1152-HQPA is the active metabolite of AZD-1152,a potent selective Aurora Kinase B inhibitor.AZD1152 is 50-fold selective for Aurora kinase B over Aurora kinase C and over 1000-fold selective for Aurora kinase B over Aurora Kinase A.(IC50s:aurora-A,1,369nmol/L;aurora-B,0.36 nmol/L;aurora-C,17.0 nmol/L).It is converted in plasma to the active form AZD1152-HQPA,which has been shown to have antineoplastic activity in a variety of animal models and human cancer cell lines. |
别名 | AZD1152;AZD 1152;5-((7-(3-(乙基(2-羟基乙基)氨基)丙氧基)-4-喹唑啉)氨基)-N-(3-氟苯基)-1H-吡唑-3-乙酰胺;;Barasertib;5-((7-(3-(ethyl(2-hydroxyethyl)amino)propoxy)-4-quinazolinyl)amino)-n-(3-fluorophenyl)-1h-pyrazole-3-acetamide;3-[[7-[3-[Ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-1H-pyrazole-5-acetamide |
货号 | 名称 | 规格 |
KFS286 | 细胞衰老检测试剂盒(β-半乳糖苷酶检测试剂盒) | 100T |
M00150 | KRASG12C抑制剂(ARS-853) | 1mL(10mM)|1mg|5mg|10mg|25mg|50mg |
M00527 | RSK2抑制剂(CMK) | 1mL(10mM)|2mg|5mg|10mg|25mg |
M01335 | PI3Kδ抑制剂(ZSTK474) | 1mL(10mM)|10mg|50mg|100mg|200mg |
M01380 | SIRT2抑制剂(Thiomyristoyl) | 1mL(10mM)|1mg|5mg|10mg|25mg|50mg|100mg |
M01829 | mTORC1和mTORC2复合体抑制剂(Palomid 529) | 1mL(10mM)|10mg|50mg|100mg |
单位名称: |
详细地址:
海淀区紫雀路33号院3号楼
|
qq:
570202610
|
联系电话: |
Email: |